Cellular and molecular mechanisms of antioxidants in Parkinson's disease

By Sutachan Jhon Jairo   Casas Zulma   Albarracin Sonia Luz   Stab Bernd Robert   Samudio Ismael   Gonzalez Janneth   Morales Ludis   Barreto George E.  

Nutritional Neuroscience, Vol. 15, Iss. 3, 2012-05 ,pp. : 120-126

Maney Publishing

Access to resources Recommend Favorite

Tetrahydrobiopterin Availability in Parkinson’s and Alzheimer’s Disease; Potential Pathogenic Mechanisms

By Foxton Richard   Land John   Heales Simon  

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 751-756

Springer Publishing Company

Access to resources Recommend Favorite

Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body Disease

By Mandal Pravat   Pettegrew Jay   Masliah Eliezer   Hamilton Ronald   Mandal Ratna  

Neurochemical Research, Vol. 31, Iss. 9, 2006-09 ,pp. : 1153-1162

Springer Publishing Company

Access to resources Recommend Favorite

Can anti-inflammatory agents protect against Parkinson’’s disease?

By Ritz Beate   Wahner Angelika D   Bordelon Yvette   Bronstein Jeff M  

Future Neurology, Vol. 3, Iss. 2, 2008-03 ,pp. : 107-111

Future Medicine

Access to resources Recommend Favorite

Presynaptic mechanisms of motor fluctuations in Parkinson’s disease: a probabilistic model

By de la Fuente‐Fernández Raúl   Schulzer Michael   Mak Edwin   Calne Donald B.   Stoessl A. Jon  

Brain, Vol. 127, Iss. 4, 2004-04 ,pp. : 888-899

Oxford University Press

Access to resources Recommend Favorite